While we all gently weep – 

Jan. 16, 2021 – On Thursday, HHS officials did just that: physicians are no longer required to have a waiver to prescribe buprenorphine — just a DEA registration that nearly every doctor in the country already needs to prescribe drugs.

“The medical evidence is clear: access to medication-assisted treatment, including buprenorphine that can be prescribed in office-based settings, is the gold standard for treating individuals suffering from opioid use disorder,” Adm. Brett P. Giroir, assistant secretary for health, said in a news release. “Removing some of the certification requirements for an X-waiver for physicians is a step toward providing more people struggling with this chronic disease access to medication assisted treatment.”

Some restrictions remain around prescribing buprenorphine. Physicians without x-waivers can only treat patients in their own state, and the new directives are limited to doctors; nurse practitioners and physicians’ assistants still need an x-waiver to prescribe the drug.



Subscribe Today! Your best source of current news, information and opinion about the issues that matter to you most. Serving the treatment industry, recovery community and health and wellness professionals.